We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NES
276
New England Securities
New York
$111K +$120K +2,348 New
PAM
277
Paradigm Asset Management
New York
$109K +$117K +2,300 New
Creative Planning
278
Creative Planning
Kansas
$98K +$106K +2,077 New
OA
279
OFI Advisors
Pennsylvania
$97K +$105K +2,058 New
ECM
280
ETrade Capital Management
Virginia
$95K +$102K +2,000 New
TWA
281
TCI Wealth Advisors
Arizona
$95K +$102K +2,000 New
ClearBridge Investments
282
ClearBridge Investments
New York
$92K +$98.5K +1,935 New
EWM
283
Evercore Wealth Management
New York
$89K +$94.2K +1,850 New
FFC
284
First Financial Corp
Indiana
$89K +$95.7K +1,880 New
TRCT
285
Tower Research Capital (TRC)
New York
$85K +$91K +1,788 New
Bessemer Group
286
Bessemer Group
New Jersey
$84K +$90.3K +1,774 New
SF
287
Synovus Financial
Georgia
$83K +$89.6K +1,760 New
MFS
288
MSI Financial Services
Massachusetts
$66K +$71K +1,394 New
BTS
289
BB&T Securities
Virginia
$60K +$6.46M +126,772 New
CTC
290
Central Trust Company
Missouri
$58K +$62.1K +1,220 New
PTC
291
Private Trust Company
Ohio
$55K +$58.9K +1,157 New
FANJ
292
Financial Architects (New Jersey)
New Jersey
$54K +$58.8K +1,155 New
AFC
293
AFT Forsyth & Company
Florida
$52K +$56K +1,100 New
CGT
294
Capital Guardian Trust
California
$52K +$56K +1,100 New
1IC
295
1919 Investment Counsel
Maryland
$48K +$50.9K +1,000 New
CA
296
CapWealth Advisors
Tennessee
$47K +$50.9K +1,000 New
DBT
297
Dubuque Bank & Trust
Iowa
$47K +$50.9K +1,000 New
KPCM
298
Kings Point Capital Management
New York
$47K +$50.9K +1,000 New
SSG
299
Summit Securities Group
New York
$47K +$50.9K +1,000 New
IRS
300
Invictus RG (Singapore)
Singapore
$44K +$47.9K +940 New
10 11
12
13 14

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.